Total Payments
$228,685
2024 Payments
$55,273
Companies
50
Transactions
1,003
Medicare Patients
5,252
Medicare Billing
$242,505
Payment Breakdown by Category
Other$201,692 (88.2%)
Food & Beverage$14,876 (6.5%)
Travel$11,960 (5.2%)
Education$156.71 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $201,692 | 88 | 88.2% |
| Food and Beverage | $14,876 | 882 | 6.5% |
| Travel and Lodging | $11,960 | 27 | 5.2% |
| Education | $156.71 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $207,355 | 329 | $0 (2024) |
| Mylan Specialty L.P. | $12,157 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,028 | 71 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,335 | 100 | $0 (2024) |
| PFIZER INC. | $624.70 | 62 | $0 (2021) |
| Lilly USA, LLC | $410.63 | 40 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $330.71 | 37 | $0 (2019) |
| Grifols USA, LLC | $315.66 | 17 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $303.27 | 35 | $0 (2020) |
| Philips Electronics North America Corporation | $294.57 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55,273 | 114 | GlaxoSmithKline, LLC. ($42,658) |
| 2023 | $38,219 | 101 | GlaxoSmithKline, LLC. ($37,301) |
| 2022 | $61,137 | 103 | GlaxoSmithKline, LLC. ($60,290) |
| 2021 | $48,512 | 102 | GlaxoSmithKline, LLC. ($47,579) |
| 2020 | $19,153 | 39 | GlaxoSmithKline, LLC. ($18,877) |
| 2019 | $1,361 | 92 | Boehringer Ingelheim Pharmaceuticals, Inc. ($226.30) |
| 2018 | $2,528 | 229 | GlaxoSmithKline, LLC. ($296.24) |
| 2017 | $2,502 | 223 | Boehringer Ingelheim Pharmaceuticals, Inc. ($271.58) |
All Payment Transactions
1,003 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $143.38 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Immunology | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $110.08 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $396.47 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $114.32 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $23.32 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $21.72 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Airway Clearance Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,065 | 1,122 | $134,339 | $58,881 |
| 2022 | 13 | 1,119 | 1,217 | $137,294 | $57,912 |
| 2021 | 13 | 1,761 | 1,917 | $183,236 | $76,929 |
| 2020 | 15 | 1,307 | 1,435 | $129,540 | $48,782 |
Total Patients
5,252
Total Services
5,691
Medicare Billing
$242,505
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 187 | $34,582 | $16,318 | 47.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $22,304 | $9,898 | 44.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 59 | 59 | $20,296 | $9,482 | 46.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 55 | $14,012 | $6,764 | 48.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 104 | $13,479 | $6,415 | 47.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $7,031 | $3,673 | 52.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 116 | 121 | $3,509 | $1,025 | 29.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,112 | $906.27 | 42.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 36 | 36 | $2,855 | $868.96 | 30.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 115 | 119 | $4,760 | $863.52 | 18.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 116 | 121 | $2,541 | $756.28 | 29.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 57 | 62 | $1,798 | $525.48 | 29.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 58 | 62 | $2,480 | $448.92 | 18.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 59 | 64 | $1,344 | $401.40 | 29.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $707.00 | $389.62 | 55.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 11 | 11 | $529.00 | $146.82 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 260 | $46,280 | $21,615 | 46.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 79 | 79 | $27,176 | $11,985 | 44.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $13,872 | $5,941 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 94 | $11,092 | $5,848 | 52.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 49 | $11,760 | $5,755 | 48.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 54 | 56 | $4,375 | $1,290 | 29.5% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 93 | 101 | $2,929 | $838.74 | 28.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 93 | 100 | $4,671 | $726.95 | 15.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 90 | 93 | $2,697 | $719.61 | 26.7% |
About Dr. Daniel Paul, MD
Dr. Daniel Paul, MD is a Internal Medicine healthcare provider based in Rogers, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841266319.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Paul, MD has received a total of $228,685 in payments from pharmaceutical and medical device companies, with $55,273 received in 2024. These payments were reported across 1,003 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($201,692).
As a Medicare-enrolled provider, Paul has provided services to 5,252 Medicare beneficiaries, totaling 5,691 services with total Medicare billing of $242,505. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Rogers, AR
- Active Since 02/24/2006
- Last Updated 05/03/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841266319
Products in Payments
- TRELEGY ELLIPTA (Drug) $93,951
- AREXVY (Drug) $58,867
- NUCALA (Biological) $17,247
- YUPELRI (Drug) $11,919
- OFEV (Drug) $831.46
- BREZTRI (Drug) $521.99
- TEZSPIRE (Biological) $422.52
- SYMBICORT (Drug) $351.33
- DUPIXENT (Biological) $323.79
- CHANTIX (Drug) $318.11
- Prolastin-C Liquid (Biological) $299.02
- XARELTO (Drug) $262.95
- TRULICITY (Drug) $243.88
- ANORO (Drug) $236.33
- ENTRESTO (Drug) $187.25
- LYRICA (Drug) $185.38
- AIRSUPRA (Drug) $185.37
- Amitiza (Drug) $179.34
- XIFAXAN (Drug) $174.82
- Yupelri (Drug) $166.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rogers
Stuart Benson, D.o, D.O
Internal Medicine — Payments: $39,908
Internal Medicine $39,908
Dr. Kiran Kurichety, Md, MD
Internal Medicine — Payments: $15,406
Internal Medicine $15,406
Lance Weathers, Md, MD
Internal Medicine — Payments: $10,694
Internal Medicine $10,694
Dr. Douglas Eddy, M.d, M.D
Internal Medicine — Payments: $10,266
Internal Medicine $10,266
Dr. Michael Garone, D.o, D.O
Internal Medicine — Payments: $5,985
Internal Medicine $5,985
James Baker, Do, DO
Internal Medicine — Payments: $5,557
Internal Medicine $5,557